Genetic testing for hereditary breast cancer in Poland: 1998–2022

BRCA1 and BRCA2 mutations contribute to both breast cancer and ovarian cancer worldwide. In Poland approximately 4% of patients with breast cancers and 10% of patients with ovarian cancer carry a mutation in BRCA1. The majority of mutations consist of three founder mutations. A rapid inexpensive tes...

Descripción completa

Detalles Bibliográficos
Autores principales: Gronwald, Jacek, Cybulski, Cezary, Huzarski, Tomasz, Jakubowska, Anna, Debniak, Tadeusz, Lener, Marcin, Narod, Steven A, Lubinski, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10262348/
https://www.ncbi.nlm.nih.gov/pubmed/37312208
http://dx.doi.org/10.1186/s13053-023-00252-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10262348/
https://www.ncbi.nlm.nih.gov/pubmed/37312208
http://dx.doi.org/10.1186/s13053-023-00252-6

Ejemplares similares